Pan Asian Microvent Tech (688386.SH) has received approval from the Shanghai Stock Exchange for the issuance of shares to specific entities.
FanAsia Microfiltration (688386.SH) issued an announcement that on December 19, 2025, the company received an "Exchange Opinion on the Issuance of Shares to Specific Objects by Jiangsu FanAsia Microfiltration Technology Co., Ltd." from the Shanghai Stock Exchange. The specific opinions include: "Jiangsu FanAsia Microfiltration Technology Co., Ltd.'s application to issue shares to specific objects meets the issuance conditions, listing conditions, and information disclosure requirements. Our Exchange will submit the application documents to the China Securities Regulatory Commission after receiving them from your company."
Pan Asian Microvent Tech (688386.SH) announced that on December 19, 2025, the company received a "Review Opinion on the Issuance of Stocks to Specific Objects by Jiangsu Pan Asian Microvent Tech Technology Co., Ltd. " issued by the Shanghai Stock Exchange. The specific review opinion is as follows: "Jiangsu Pan Asian Microvent Tech Technology Co., Ltd.'s application to issue stocks to specific objects meets the issuance conditions, listing conditions, and information disclosure requirements. We will submit the application documents to the China Securities Regulatory Commission after receiving them from your company."
Related Articles
MOODY TECH HLDG (01400) has signed a memorandum of understanding with Yuanzhu Zaocheng to expand sales and customer base in the digital marketing business.
The major shareholder, West Lake Electronics Group, of Wasu Media Holding (000156.SZ) plans to reduce its shareholding by no more than 1%.
Jiangsu Hengrui Pharmaceuticals (01276): Approval granted to conduct clinical trials for injection of lysozyme microspheres.
MOODY TECH HLDG (01400) has signed a memorandum of understanding with Yuanzhu Zaocheng to expand sales and customer base in the digital marketing business.
The major shareholder, West Lake Electronics Group, of Wasu Media Holding (000156.SZ) plans to reduce its shareholding by no more than 1%.
Jiangsu Hengrui Pharmaceuticals (01276): Approval granted to conduct clinical trials for injection of lysozyme microspheres.
